GB2318792B - Unactivated oocytes as cytoplast recipients for nuclear transfer - Google Patents
Unactivated oocytes as cytoplast recipients for nuclear transferInfo
- Publication number
- GB2318792B GB2318792B GB9802916A GB9802916A GB2318792B GB 2318792 B GB2318792 B GB 2318792B GB 9802916 A GB9802916 A GB 9802916A GB 9802916 A GB9802916 A GB 9802916A GB 2318792 B GB2318792 B GB 2318792B
- Authority
- GB
- United Kingdom
- Prior art keywords
- time
- embryo
- transfer
- oocyte
- nucleus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000000287 oocyte Anatomy 0.000 title abstract 3
- 210000001161 mammalian embryo Anatomy 0.000 abstract 4
- 241001465754 Metazoa Species 0.000 abstract 3
- 230000009261 transgenic effect Effects 0.000 abstract 2
- 230000035519 G0 Phase Effects 0.000 abstract 1
- 230000010190 G1 phase Effects 0.000 abstract 1
- 229940122255 Microtubule inhibitor Drugs 0.000 abstract 1
- KYRVNWMVYQXFEU-UHFFFAOYSA-N Nocodazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CS1 KYRVNWMVYQXFEU-UHFFFAOYSA-N 0.000 abstract 1
- 230000004913 activation Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000022131 cell cycle Effects 0.000 abstract 1
- 210000000805 cytoplasm Anatomy 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 230000031864 metaphase Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000782 microtubule inhibitor Toxicity 0.000 abstract 1
- 229950006344 nocodazole Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
A method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division. The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time. The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor much as nocodazole. The reconstituted embryo may then give rise to one or more live animal births. The invention is useful in the production of transgenic animals as well as non-transgenics of high genetic merit.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9926730A GB2340493B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
GB9802916A GB2318792B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9517779.6A GB9517779D0 (en) | 1995-08-31 | 1995-08-31 | Biological manipulation |
PCT/GB1996/002098 WO1997007668A1 (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
GB9802916A GB2318792B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9802916D0 GB9802916D0 (en) | 1998-04-08 |
GB2318792A GB2318792A (en) | 1998-05-06 |
GB2318792B true GB2318792B (en) | 2000-06-21 |
Family
ID=26307655
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9802916A Expired - Fee Related GB2318792B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
GB9926730A Expired - Fee Related GB2340493B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9926730A Expired - Fee Related GB2340493B (en) | 1995-08-31 | 1996-08-30 | Unactivated oocytes as cytoplast recipients for nuclear transfer |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2318792B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2265909A (en) * | 1992-04-01 | 1993-10-13 | Inst Of Animal Physiology And | Nuclear transplantation |
WO1994006422A1 (en) * | 1992-09-22 | 1994-03-31 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Use of taxol for treating lymphomas and breast cancer |
WO1995003795A1 (en) * | 1993-07-29 | 1995-02-09 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9308271D0 (en) * | 1993-04-21 | 1993-06-02 | Univ Edinburgh | Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method |
-
1996
- 1996-08-30 GB GB9802916A patent/GB2318792B/en not_active Expired - Fee Related
- 1996-08-30 GB GB9926730A patent/GB2340493B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2265909A (en) * | 1992-04-01 | 1993-10-13 | Inst Of Animal Physiology And | Nuclear transplantation |
WO1994006422A1 (en) * | 1992-09-22 | 1994-03-31 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Use of taxol for treating lymphomas and breast cancer |
WO1995003795A1 (en) * | 1993-07-29 | 1995-02-09 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
Non-Patent Citations (7)
Title |
---|
Biology of Reproduction 1990,43(5),877-884 * |
Biology of Reproduction 1993,49(5),933-942 * |
J.Cell Science 1984,69,19-34 * |
Molecular Reproduction and Development 1994,39(2),147-152 * |
Nature 1986,320(6),63-65 * |
The Wistar Institute Symposium Monograph 1969,1,19-33 * |
Theriogenology 1996,45(1),287 * |
Also Published As
Publication number | Publication date |
---|---|
GB9802916D0 (en) | 1998-04-08 |
GB2318792A (en) | 1998-05-06 |
GB2340493A (en) | 2000-02-23 |
GB2340493B (en) | 2000-06-21 |
GB9926730D0 (en) | 2000-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG75919A1 (en) | Unactivated oocytes as cytoplast recipients for nuclear transfer | |
GB2318578A (en) | Quiescent cell populations for nuclear transfer | |
ES2246227T8 (en) | Nucleic acid molecules encoding alternansacarase | |
AU2002361327A1 (en) | Exogenous protein expression system in an avian system | |
EP0938550A4 (en) | CULTURE OF A CELL LINE FROM THE INNER CELL SIZE OF HIP ANIMAL EMBRYONS. | |
CY1105006T1 (en) | METHOD OF PRODUCING AND RAISING CHICKS, AS WELL AS HATCHING ARRANGEMENT AND CHICK FARM FOR CARRYING OUT THE METHOD | |
DK0485044T3 (en) | Plasmids for the production of transgenic plants modified for growth form and yield | |
EP1198169A4 (en) | A process of cell reprogramming through production of a heterokaryon | |
NO882469D0 (en) | PROCEDURE FOR PRODUCING PROTEINS USING USE-INJURABLE EXPRESSION SYSTEMS IN GENETICALLY MODIFIED EUCARYOTIC HOST CELLS FORMED IN VIVO. | |
NZ336493A (en) | A method of oocyte enucleation and production of reconstituted embryos | |
GB2318792B (en) | Unactivated oocytes as cytoplast recipients for nuclear transfer | |
GB2369828A (en) | Nuclear transfer with selected donor cells | |
Miki et al. | Cytoplasmic asters are required for progression past the first cell cycle in cloned mouse embryos | |
WO2000025578A3 (en) | Methods for cloning animals | |
GB2331751B (en) | Quiescent cell populations for nuclear transfer | |
DE60041771D1 (en) | METHOD FOR TRANSFERRING SPERMATONIAL GERM CELLS ON CROPS | |
DE59814285D1 (en) | EFFICIENT CORE TRANSFER WITH PRIMORDIAL GERM CELLS | |
RU98105617A (en) | INACTIVATED OOCYTES AS RECIPIENT CYTOPLASTS FOR NUCLEAR TRANSFER | |
Latham et al. | Modelling Habituation of Introduced Predators to Unrewarding Bird Odors for Conservation of Ground-Nesting Shorebirds | |
김선균 et al. | In vitro Development of Somatic Cell Nuclear Transferred Bovine Embryos Following Activation Timing in MII Enucleated Oocytes Cryopreservation | |
BG49622A1 (en) | Method for obtaining male- sterile plants at the sunflower |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20130830 |